Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 18, 2024
E-Cadherin Mutational Landscape and Outcomes in Breast Invasive Lobular Carcinoma
Lounes Djerroudi, Amel Bendali, Laetitia Fuhrmann, et al.
Cell Metabolism
|
September 25, 2018
PML-Regulated Mitochondrial Metabolism Enhances Chemosensitivity in Human Ovarian Cancers
Géraldine Gentric, Yann Kieffer, Virginie Mieulet, et al.
Nature Communications
|
January 23, 2020
Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms
Floriane Pelon, Brigitte Bourachot, Yann Kieffer, et al.
NPJ Breast Cancer
|
February 13, 2025
Clinico-pathological factors predicting pathological response in early triple-negative breast cancer
Clara Helal, Lounes Djerroudi, Toulsie Ramtohul, et al.
Cancer Cell
|
February 20, 2018
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
Ana Costa, Yann Kieffer, Alix Scholer-Dahirel, et al.
Radiology
|
July 1, 2025
Posttreatment MRI to Predict Pathologic Complete Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy
Toulsie Ramtohul, Derek Lollivier, Justine Spriet, et al.
Gynecologic Oncology
|
June 26, 2026
Prognostic impact of time to first recurrence in low-grade serous ovarian carcinoma: A multicentric retrospective study from the French TMRG network
Thomas Montassier, Enora Laas, Judicael Hotton, et al.
Journal of Gynecologic Oncology
|
July 7, 2026
Efficacy of secondary cytoreductive surgery for relapsed ovarian low-grade serous carcinoma: a multicenter analysis from French TMRG network
Thomas Gaillard, Judicael Hotton, Enora Laas, et al.
Nature Communications
|
February 12, 2024
Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway
Monika Licaj, Rana Mhaidly, Yann Kieffer, et al.
Iscience
|
March 19, 2026
CMV seropositivity associates with poor clinical outcome in triple negative breast cancer
Romain-David Seban, Constance Lamy, Luc Cabel, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 18, 2024
E-Cadherin Mutational Landscape and Outcomes in Breast Invasive Lobular Carcinoma
Lounes Djerroudi, Amel Bendali, Laetitia Fuhrmann, et al.
Cell Metabolism
|
September 25, 2018
PML-Regulated Mitochondrial Metabolism Enhances Chemosensitivity in Human Ovarian Cancers
Géraldine Gentric, Yann Kieffer, Virginie Mieulet, et al.
Nature Communications
|
January 23, 2020
Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms
Floriane Pelon, Brigitte Bourachot, Yann Kieffer, et al.
NPJ Breast Cancer
|
February 13, 2025
Clinico-pathological factors predicting pathological response in early triple-negative breast cancer
Clara Helal, Lounes Djerroudi, Toulsie Ramtohul, et al.
Cancer Cell
|
February 20, 2018
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
Ana Costa, Yann Kieffer, Alix Scholer-Dahirel, et al.
Radiology
|
July 1, 2025
Posttreatment MRI to Predict Pathologic Complete Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy
Toulsie Ramtohul, Derek Lollivier, Justine Spriet, et al.
Gynecologic Oncology
|
June 26, 2026
Prognostic impact of time to first recurrence in low-grade serous ovarian carcinoma: A multicentric retrospective study from the French TMRG network
Thomas Montassier, Enora Laas, Judicael Hotton, et al.
Journal of Gynecologic Oncology
|
July 7, 2026
Efficacy of secondary cytoreductive surgery for relapsed ovarian low-grade serous carcinoma: a multicenter analysis from French TMRG network
Thomas Gaillard, Judicael Hotton, Enora Laas, et al.
Nature Communications
|
February 12, 2024
Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway
Monika Licaj, Rana Mhaidly, Yann Kieffer, et al.
Iscience
|
March 19, 2026
CMV seropositivity associates with poor clinical outcome in triple negative breast cancer
Romain-David Seban, Constance Lamy, Luc Cabel, et al.
Page
of 7